Scientists stop colon cancer growth in mice by blocking just one enzyme
GALVESTON, Texas -- Texas researchers have discovered what may become a potent new weapon in the fight against colon cancer.

GALVESTON, Texas -- Texas researchers have discovered what may become a potent new weapon in the fight against colon cancer.
The Food and Drug Administration on Wednesday approved Amgen Inc.'s application for its drug Vectibix to treat colon cancer patients who are receiving chemotherapy.
The U.S. Food and Drug Administration said on Wednesday it had approved Amgen Inc's drug Vectibix for the treatment of advanced colon cancer.
BOSTON, Sept. 27 (UPI) -- Researchers at Boston's Dana-Farber Cancer Institute have developed a series of questions to calculate a person's odds of developing a form of colon cancer.
In our Health Alert, there's a new tool that could help determine if you're at genetic risk for colon cancer.
Contact:
Copyright © 2005 Colon Cancer Solutions.com All Rights Reserved